Featured Research

from universities, journals, and other organizations

CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation

Date:
August 12, 2009
Source:
World Journal of Gastroenterology
Summary:
Conventional ultrasound including 2D and Doppler ultrasound plays an important role in screening for postoperative vascular complications after liver transplantation, but vascular visualization is not always satisfactory.

Conventional ultrasound including 2D and Doppler ultrasound plays an important role in screening for postoperative vascular complications after liver transplantation, but vascular visualization is not always satisfactory.

A research article to be published on August 7, 2009 in the World Journal of Gastroenterology addresses this question. Contrast-enhanced ultrasound (CEUS) has been applied gradually in recent years because of its fine vascular tracing and perfusion visualization.

A research team led by Professor Yan Luo from West China Hospital found that CEUS improved the flow visualization of the hepatic artery, portal and hepatic veins and bridging vein, as well as evaluation of liver graft parenchyma perfusion.

CEUS has high sensitivity and specificity for finding hepatic artery thrombosis, hepatic artery stenosis, portal vein thrombosis and liver infarction. CEUS can be performed at the bedside, and has no iodine allergy or X-ray exposure. Therefore, this new technique should be used more frequently after liver transplantation.

Although this study included a limited number of patients, the research is interesting and the results are useful for diagnosis of vascular complications early after liver transplantation.


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Luo Y, Fan YT, Lu Q, Li B, Wen TF, Zhang ZW. CEUS: A new imaging approach for postoperative vascular complications after right-lobe LDLT. World J Gastroenterol, 2009; 15(29): 3670-3675 [link]

Cite This Page:

World Journal of Gastroenterology. "CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation." ScienceDaily. ScienceDaily, 12 August 2009. <www.sciencedaily.com/releases/2009/08/090812092146.htm>.
World Journal of Gastroenterology. (2009, August 12). CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/08/090812092146.htm
World Journal of Gastroenterology. "CEUS: To Diagnose Postoperative Vascular Complications After Liver Transplantation." ScienceDaily. www.sciencedaily.com/releases/2009/08/090812092146.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins